Introduction: Resistance against commonly used antibacterial agents has become a globally recognized threat to human health. Therefore, the development of new and effective antibacterial agents is necessary to treat infections caused by resistant bacterial strains; plants are a promising source of new agents to be tested. Methodology: The minimum inhibitory concentrations (MIC) of ethanolic extracts of Erodium gruinum, Euphorbia hierosolymitana, Logoecia cuminoides, and Tamarix tetragyna against 10 Gram-negative and 5 Gram-positive bacteria were determined using agar well diffusion and microtiter plate dilution methods, respectively. The phytochemical composition of the crude extracts of the plants was determined using HPLC. Results: Pseudomonas aeruginosa ATCC 27853, Klebsiella pneumoniae, Proteus mirabilis, and Acinetobacter baumannii were sensitive to E. gruinum and E. hierosolymitana extracts. P. aeruginosa ATCC 27853 and M. catarrhalis were sensitive to L. cuminoides extract. P. aeruginosa ATCC 27853, P. mirabilis, and K. pneumoniae were sensitive to T. tetragyna extracts. For Gram-positive bacteria, Staphylococcus aureus ATCC 33591 and ATCC 43300 were sensitive to E. gruinum and E. hierosolymitana extracts. S. aureus ATCC 43300 and ATCC 33591 and Group D Streptococcus were sensitive to T. tetragyna extract. All Gram-positive bacteria were completely resistant to the extract of L. cuminoides. The major phytochemical components of the plant extracts belonged to flavonoids, tannins, terpenes, quinones, phytosterols, phytoestrogens, carbohydrates, fatty acids, and coumarin. Conclusion: The study showed the potential of the development of antibacterial agents from these plants. Phytochemical analysis revealed compounds that are candidates for new antibacterial drugs.
Introduction
Antibacterial therapy has been the mainstay treatment of bacterial infections for many decades. However, the misuse of antibiotics has led to the development of multi-drug-resistant (MDR) pathogens [1, 2] . In recent years, there has been an alarming and threatening increase in infections caused by MDR pathogens [3] , which have become a significant cause of death especially in children, the elderly, and immunocompromised patients [3] . In addition, infections by MDR pathogens have been associated with serious economic impacts due to higher morbidity, increased hospital stays, and increased health care costs [3] .
During the last few decades, the rate of the discovery and the development of new antibacterial agents has declined. Therefore, the development of new, effective, and affordable antibacterial agents has become a high priority in the medical community.
Many medicinal plants have been used in traditional medicine for centuries in the treatment of a variety of ailments [2] . Medicinal plants contain a vast array of substances that can be used to treat chronic and infectious diseases [4, 5] . The antibacterial activity of various plant extracts obtained using a number of organic solvents such as ethanol, methanol, acetone, and water has been reported [5] [6] [7] [8] .
In folk medicine, E. gruinum has been used for its antioxidant, antiviral, bactericidal, antileishmanial, and hemostatic effects [9] . E. hierosolymitana has been used in the treatment of skin and hair problems, wounds, eczema, psoriasis, warts, and as a purgative [10] . It was found to act as a protease inhibitor and to have allelopathic, antibacterial, and antifungal effects [11] . Recently, E. hierosolymitana has been used in the treatment of ovarian, breast, and prostate cancers [12] . Logoecia cuminoides has been used for the treatment of Leishmaniasis, bile stones, diarrhea, and abdominal pain [13] . Studies have shown that L. cuminoides has antioxidant and antimicrobial effects [14] . Tamarix tetragyna is also believed to have antioxidant, antibacterial, and α-glucosidase inhibitive effects, as well as antitumor, and hepatoprotective activities [15] .
To date, many published research papers have focused on listing and classifying medicinal plants using ethnopharmacological or ethnobotanical techniques, while only a few have focused on the pharmacological activities of specific bioactive compounds in these plants. Therefore, the objective of the present study was to determine the phytochemical compositions of four medicinal plants in order to evaluate the antibacterial activities of their ethanolic extracts against 15 bacterial strains.
Methodology

Extraction
Four wild-grown plants were used in the study. Various parts of each plant, including leaves, flowers, and stems, were selected at random to determine their antibacterial activities. The plants were E. gruinum (leaves and flowers), E. hierosolymitana (leaves and stems), L. cuminoides (leaves and stems), and T. tetragyna (leaves, flowers, and stems). Extraction was performed according to previously published methods [2] . Briefly, the freshly collected plants were washed and left to air-dry in a dark place at room temperature for five to seven days. Selected plant parts were then ground using a laboratory grinder (Thomas Scientific, Swedesboro, USA). The plant extracts were prepared by adding ultrapure ethanol (99.7%; Merck, Darmstadt, Germany) to the ground plant material at a ratio of 1:3 (w/v). The mixture was incubated under continuous stirring at room temperature (23°C) for 72 hours in the dark. Then the extracts were filtered through Whatman No. 1 filter paper (Merck, Darmstadt, Germany). Ethanol was evaporated at 50°C for 45-60 min under negative pressure (12 mbar) and continuous rotation using a rotary evaporator (Stuart, Staffordshire, UK) until complete dryness.
High Performance Liquid Chromatography (HPLC)
Determination of the plant extracts' phytochemical composition was performed using HPLC [14] . Approximately 50 mg of each of the ground plant materials was placed in a 5 mL glass amber tube (Thomas Scientific, Swedesboro, USA) and 1.5 mL of HPLC-grade methanol was added. The mixture was then vortexed gently for three to five minutes three times (Vortex; Fisher Scientific, Pittsburgh, USA). The tube was then centrifuged at 10,000 g for 5 minutes. The supernatant was filtered using a 0.45 μm PTFE syringe filter (Merck, Darmstadt, Germany). Chromatographic separation of the plant extracts was performed using the Shimadzu HPLC (Shimadzu Scientific Instruments, Addison, USA). The PrimeSIL C18 column (Wesley Technologies, Inc., Suwanee, USA) used an isocratic mobile phase of water (0.1% formic acid): acetonitrile (0.1% formic acid) (10:90, v/v) at a flow rate of 0.2 mL/min for 11 minutes and column temperature of 40°C. The temperature of the auto sampler was maintained at 4°C and the injection volume was 20 µL. For mass spectrometry, an electrospray ionization (ESI) interface was used with positive and negative screening modes at 3 KV capillary voltage, 120°C source block temperature, and 45°C desolation gas temperature.
Preparation of Bacterial Strains
All bacteria used in this study were from the American Type Culture Collection (ATCC) bacterial strains. In total, 10 Gram-negative and 5 Gram-positive bacterial quality control strains were used. Bacterial strains were cultured onto Luria-Bertani (LB) agar, except for Pseudomonas strains that were cultured onto King's B (KB) agar, and for Streptococcus and Moraxella that were cultured onto Mueller Hinton agar (Mast Group Ltd., Bootle, UK) supplemented with 5% sheep's blood. The plates were incubated for 24 hours for all bacterial strains except for Pseudomonas, Streptococcus and Moraxella, which were incubated for 48 hours. Carbon dioxide incubator (under 5%) was used for Streptococcus and Moraxella. Bacterial subcultures were suspended in nutrient broth, supplemented with 15% glycerol, and in case of Streptococcus and Moraxella, 5% sheep's blood was added and then stored at -70°C for further use.
Preparation of the Plant Extracts for Antibacterial Activity
To obtain a final stock concentration of 100 mg/mL, 10 g of the powdered plant extract was dissolved in 100 mL of DMSO. The stock solution of the plant extract (100 mg/mL) was further diluted using 0.1% DMSO (prepared with sterile distilled water) to 1 mg/mL for agar well diffusion assay and 0.2 mg/mL for MIC assay.
Antibacterial Activity of the Plant Extracts
The antibacterial activity of the plant extracts was investigated using the agar well diffusion method [6] . Briefly, 100 µL of bacterial suspension containing approximately 10 7 CFU/mL was seeded on Mueller Hinton agar supplemented with 5% sheep's blood for Streptococcus and Moraxella (Mast Group Ltd., Bootle, UK) plates. Then, 4.0 mm diameter wells were punched into the agar plate and 10.0 µL of the plant extract (1 mg/mL) were loaded into each well. 10.0 µL of 0.1% DMSO and 10.0 µL chloramphenicol (1 mg/mL) were used in each plate. The plates were then incubated at 37 o C for 24 hours for all bacterial strains except for Pseudomonas, Streptococcus and Moraxella, which were incubated for 48 hours. Carbon dioxide incubator (under 5%) was used for Streptococcus and Moraxella. Each plant extract was investigated in three replicates. The inhibition zones (mm) were measured and the average of the three replicates was calculated.
Determination of Minimum Inhibitory Concentration (MIC)
The MICs of the plant extracts for bacterial strains identified by their sensitivity to that extract by well diffusion were determined in triplicate using microtiter plate dilution [12, 16] . Positive and negative controls were used in each plate: chloramphenicol and 0.1% DMSO, respectively. Initially, the first well was filled with 180 μL and the second to the tenth well with 100 μL of MHB supplemented with 5% sheep's blood for Streptococcus and Moraxella. Twenty microliters (20 μL) of the plant extracts (0.2 mg/mL) were added in the first well to get concentration of (10µg/mL). Then 100μL was transferred from the first well to the second and so on by two-fold dilution to get concentrations of 20 -0.04 µg/mL in the plate. Then, each well was inoculated with 100 μL of approximately 1 McFarland standard of freshly grown bacteria, making the final concentration in the wells in the range 10 -0.02 µg/mL. Bacterial growth was examined visually after incubation at 37 o C for 24 hours for all bacterial strains except for Pseudomonas, Streptococcus and Moraxella, which were incubated for 48 hours. A carbon dioxide incubator (under 5%) was used for Streptococcus and Moraxella. The MIC was determined visually as the lowest concentration that led to bacterial growth inhibition.
Statistical Analysis
Analysis of variance (ANOVA) was conducted using SAS 9.4 (SAS Institute Inc., USA). Differences among treatment means were determined by Least Significant Difference (LSD) test at 5% confidence interval. Significant values were considered from p ≤ 0.05.
Results
Antibacterial activity by well diffusion
Antibacterial activities of the ethanolic plant extracts against 10 Gram-negative bacterial strains are presented in Table 1 . Table 1 . Antibacterial activity of ethanolic plant extracts against some Gram-negative and Gram-positive pathogenic bacterial strains (inhibition zones in mm). For the T. tetragyna plant extract, P. aeruginosa ATCC 27853, P. mirabilis, and K. pneumoniae were found to be sensitive, whereas P. aeruginosa ATCC BAA 2114 was completely resistant. However, C. koseri and E. cloacae were less sensitive to the T. tetragyna plant extract. The largest zone of inhibition was found against P. aeruginosa ATCC 27853, followed by P. mirabilis and K. pneumoniae.
Bacterial strain
Plant extract Control
S. aureus strains ATCC 33591 and ATCC 43300 and GAS were sensitive to the extracts of E. gruinum and E. hierosolymitana plants. The inhibition zones produced by E. gruinum and E. hierosolymitana extracts were largest against S. aureus strains ATCC 33591 and ATCC 43300. GBS and GDS were completely resistant to these two plant extracts ( Table  1) .
All Gram-positive bacterial strains were completely resistant to the extract of L. cuminoides. S. aureus strains ATCC 43300 and ATCC 33591, GAS, GBS and GDS were determined to be sensitive to the extract of T. tetragyna. The zone of inhibition was greatest against GDS, followed by S. aureus ATCC 43300, S. aureus ATCC 33591 GAS and GBS.
Antibacterial activity by dilution method
The MICs of ethanolic plant extracts against 10 Gram-negative bacteria are presented in Table 2 . P. aeruginosa ATCC 27853 was the most sensitive among Gram-negative bacteria to E. gruinum and L. cuminoides extracts. K. pneumoniae and P. mirabilis were equally sensitive to the extracts of E. gruinum, E. hierosolymitana, and T. tetragyna. K. pneumoniae, P. mirabilis and P. aeruginosa ATCC27853 were most sensitive to the extract of T. tetragyna. P. aeruginosa ATCC27853 was most sensitive to the extract of E. gruinum.
S. aureus ATCC 33591 was the most sensitive to the extract of E. gruinum. S. aureus ATCC 33591 and S. aureus ATCC 43300 were the most sensitive to the extract of E. hierosolymitana. GDS was more sensitive to the extract of T. tetragyna than GBS and GAS were. Table  2) . The phytochemical composition of the crude extracts of E. gruinum (leaves and flowers), E. hierosolymitana (leaves and stems), L. cuminoides (leaves and stems), and T. tetragyna (leaves, flowers, and stems) are presented in Table 3 and Table 4 . HPLC analysis showed that the selected plants contain a wide range of chemicals including flavonoids, tannins, terpenes, quinones, phytosterols, phytoestrogens, carbohydrates, fatty acids, and coumarin compounds. The analysis showed that some plants contain phytochemicals that are only present in one plant but not in others (Table 4 ).
Discussion
The phytochemical compositions of the crude extracts of leaves and flowers of E. gruinum, leaves and stems of E. hierosolymitana and L. cuminoides, and leaves, flowers, and stems of T. tetragyna were determined in the study. The plants were particularly rich in flavonoids, terpenes, tannins, quinones, and phytoestrogens. Many of these components have been found to have distinctive medicinal activity including antibacterial, antifungal, anti-inflammatory, antioxidant and anticancer activities, and as an estrogen agonist [17] [18] [19] [20] [21] .
In the present study, HPLC analysis revealed that the plants investigated did contain unique phytochemicals. Therefore, the specific antibacterial activities of the extracts of these plants might be attributed to these particular compounds. Daidzein, a metabolite of the isoflavone, was found only in the extract of E. gruinum. The compound was reported to be metabolized in gastrointestinal system to equol by the bacteria, which are members of the intestinal flora, and equol is known to have strong estrogenic and antioxidative activities [22, 23] . Similar to other flavonoids, daidzein is believed to exert an antibacterial effect against certain Gram-positive and Gram-negative bacteria [24] . In this study, E. gruinum extract was shown to have promising antibacterial activity against P. aeruginosa ATCC 27853, K. pneumoniae, P. mirabilis, A. baumannii, and S. aureus.
The inhibition of P. aeruginosa by the ethanolic extract of E. gruinum may also be attributed to apigenin, which is another flavonoid known to have antibacterial activity against several pathogenic bacteria including P. aeruginosa, Salmonella Typhimurium, P. mirabilis, K. pneumoniae, and Enterobacter aerogenes [24] .
The extract of E. hierosolymitana was found to contain 1-octen-3-ol, which is a mushroom alcohol that has been shown to have strong antifungal and antibacterial activities against Gram-positive bacteria including S. aureus, Staphylococcus epidermidis, and Bacillus subtilis [25] . In the present study, the same metabolite was confirmed to be present in E. hierosolymitana and the anti-staphylococcal activity may result from the presence of this metabolite. αpinene, which was also detected in the extract of E. hierosolymitana in the study, is an eugenol of the allylbenzene chemical compounds and has been shown to have a fungicidal effect against Candida albicans and a bactericidal effect against methicillin-resistant S. aureus [26] . Therefore, the anti-staphylococcal effect of E. hierosolymitana extract detected in our study may be attributable to eugenol. Kaempferol (astragalin), which was detected in E. hierosolymitana, is a flavonoid that is well known for its wide range of bioactive functions including anti-inflammatory, antioxidant, neuroprotective, cardioprotective, anti-obesity, antiosteoporotic, anti-cancer, anti-ulcer, and anti-diabetic properties [27, 28] .
The extract of T. tetragyna was found to contain several unique compounds. Ellagic acid (EA) is a herbal polyphenol that is considered a dimer of gallic acid [29] and was found to be bactericidal against Corynebacterium diphtheriae and bacteriostatic against B. subtilis, Clostridium sporogenes, S. aureus, Neisseria meningitidis, and M. catarrhalis [30] .
Genistein is an isoflavone with strong estrogenic and antioxidant effects [22] . In this study, genistein was found in E. hierosolymitana, E. gruinum, and T. tetragyna extracts. It could explain the antibacterial activity observed with these plant extracts against K. pneumoniae. The finding is in agreement with a previous report that genistein had antibacterial activity against K. pneumoniae [31] .
ß-sitosterol, a triterpene, was found in E. gruinum and T. tetragyna extracts. Previous reports have cited ßsitosterol as having considerable antibacterial activity against C. diphtheriae and, in parallel to our study, against S. aureus [32] .
Chlorogenic acid, a natural ester, was found in all of the plant extracts included in the study. The metabolite was shown to be effective against S. aureus, Streptococcus uberis, Streptococcus agalactiae, Streptococcus dysgalactiae, E. aerogenes, and E. coli [33] .
Quercetin is a flavonoid compound that was found in the extracts of E. gruinum, T. tetragyna, and L. cuminoides. The antibacterial activity of quercetin has been determined against a wide variety of pathogenic bacteria including E. coli, P. aeruginosa, and B. subtilis [34] .
Conclusion
The results of the study showed the promising antibacterial potential of extracts of four medicinal plants. However, further in vitro and in vivo testing of purified phytochemicals from the crude extracts of these plants is warranted to identify active components that could be used in future formulations of pharmaceuticals and in the development of new and effective antibacterial agents against common pathogenic bacteria.
